We & Win Diversification Co., Ltd.

Taipei Exchange 4113.TWO

We & Win Diversification Co., Ltd. EBIT Margin for the year ending December 31, 2023: -9.13%

We & Win Diversification Co., Ltd. EBIT Margin is -9.13% for the year ending December 31, 2023, a 88.79% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • We & Win Diversification Co., Ltd. EBIT Margin for the year ending December 31, 2022 was -81.41%, a -678.28% change year over year.
  • We & Win Diversification Co., Ltd. EBIT Margin for the year ending December 31, 2021 was 14.08%, a 174.07% change year over year.
  • We & Win Diversification Co., Ltd. EBIT Margin for the year ending December 31, 2020 was -19.01%, a -255.35% change year over year.
  • We & Win Diversification Co., Ltd. EBIT Margin for the year ending December 31, 2019 was 12.23%.
Key data
Date EBIT Margin EPS (Basic) EPS (Diluted) Shares (Basic, Weighted)
Market news
Taipei Exchange: 4113.TWO

We & Win Diversification Co., Ltd.

CEO Mr. Yung-Yi Su
IPO Date Dec. 31, 2007
Location
Headquarters No. 185, Fuguo Road
Employees 35
Sector Consumer Staples
Industries
Retail & Wholesale Oil & Gas
Description

We & Win Diversification Co., Ltd. engages in the rental and sale of real estate properties in Taiwan. It is also involved in the public construction investment; new towns and community development; wholesale of medical equipment; and international trade businesses. The company was formerly known as Oncoprobe Biotech Inc. and changed its name to We & Win Diversification Co., Ltd. in 2009. We & Win Diversification Co., Ltd. was founded in 1987 and is based in Kaohsiung City, Taiwan.

StockViz Staff

January 15, 2025

Any question? Send us an email